APA (7th ed.) Citation

Feng, W., Zhou, L., He, J., Wang, Y., Cai, J., Jiang, T., . . . Ren, T. (2025). Association of VEGFR2 polymorphisms with clinical outcomes of anti-angiogenesis therapy in cancer patients: A systematic review and meta-analysis. European Journal of Pharmacology, 990, N.PAG. https://doi.org/10.1016/j.ejphar.2025.177299

Chicago Style (17th ed.) Citation

Feng, Wenzheng, Lijun Zhou, Junyao He, Yimin Wang, Jiali Cai, Tianhao Jiang, Qingchun Zhao, and Tianshu Ren. "Association of VEGFR2 Polymorphisms with Clinical Outcomes of Anti-angiogenesis Therapy in Cancer Patients: A Systematic Review and Meta-analysis." European Journal of Pharmacology 990 (2025): N.PAG. https://doi.org/10.1016/j.ejphar.2025.177299.

MLA (9th ed.) Citation

Feng, Wenzheng, et al. "Association of VEGFR2 Polymorphisms with Clinical Outcomes of Anti-angiogenesis Therapy in Cancer Patients: A Systematic Review and Meta-analysis." European Journal of Pharmacology, vol. 990, 2025, p. N.PAG, https://doi.org/10.1016/j.ejphar.2025.177299.